Overview
The TfR Targeting Peptide is designed to facilitate the effective delivery of small molecules across critical biological barriers. This 12-mer peptide sequence targets the transferrin receptor (TfR), allowing for precise internalization into TfR-expressing cells through the natural process of endocytosis. Its unique properties make it a possible carrier for transporting therapeutic agents not only into the brain by crossing the blood-brain barrier but also into malignant tissues, enhancing treatment efficacy.
Key Features
- 12-mer peptide sequence targeting transferrin receptors.
- Facilitates endocytosis into TfR-expressing cells.
- Potential carrier for drug delivery across the blood-brain barrier.
- Enhances treatment options for malignancies and neurological disorders.
Specifications
| Property | Details |
|---|---|
| Peptide Length | 12-mer |
| Target | Transferrin Receptor (TfR) |
| Weight | 1 mg |
FAQ
What is the main use of the TfR Targeting Peptide?
The TfR Targeting Peptide is primarily used for drug delivery applications, particularly for crossing the blood-brain barrier and targeting malignant tissues.
How does the TfR Targeting Peptide work?
This peptide binds to transferrin receptors on cell surfaces and is internalized via endocytosis, allowing small molecules to be delivered directly into the cells.
Can I purchase other peptide products from AnaSpec?
Yes, AnaSpec offers a wide range of peptides, including options like PKG Substrate and Autocamtide-2suitable for various research needs.
If you’re looking for a reliable peptide that can help enhance your research on drug delivery systems, the TfR Targeting Peptide is an excellent choice. Explore our collection of peptides to find the right solutions for your projects.




Reviews
There are no reviews yet.